NCT04764643View on ClinicalTrials.gov

The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

May 31, 2021

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG

N-acetylcysteine solution

use N-acetylcysteine solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy

DRUG

sodium thiosulfate solution

use sodium thiosulfate solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy

Trial Locations (1)

710032

Xijing Hospital of Digestive Disease, Xi'an

All Listed Sponsors
lead

Xijing Hospital of Digestive Diseases

OTHER

NCT04764643 - The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy | Biotech Hunter | Biotech Hunter